Trial intelligence / Profile preview

Adjuvant alectinib versus platinum-based chemotherapy after complete resection of ALK-positive non-small cell lung cancer

2017-004331-37Phase 3Completed

Sponsor

Roche

Start

May 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1